Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Nagaendran Kandiah,1,2 Ming-Chyi Pai,3,4 Vorapun Senanarong,5 Irene Looi,6,7 Encarnita Ampil,8 Kyung Won Park,9 Ananda Krishna Karanam,10 Stephen Christopher11 1Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, 2Duke-NUS, Graduate Medical School, Singapore; 3Division...

Full description

Bibliographic Details
Main Authors: Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:Clinical Interventions in Aging
Subjects:
acetylcholinesterase
BuChE genotype
butyrylcholinesterase
Parkinson's disease dementia
rivastigmine
subcortical vascular dementia
Online Access:https://www.dovepress.com/rivastigmine-the-advantages-of-dual-inhibition-of-acetylcholinesterase-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/rivastigmine-the-advantages-of-dual-inhibition-of-acetylcholinesterase-peer-reviewed-article-CIA

Similar Items